This application is a request for renewal funding for the Training Program in Signal Transduction and Cancer (T32 CA070085) at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The Training Program in Signal Transduction and Cancer has been preparing postdoctoral trainees to work in the area of signal transduction and cancer through mentored laboratory research and a structured curriculum of seminars, journal clubs and program meetings. The preceptors are established NIH funded investigators who focus on translational research on signaling pathways in malignant cells. This training program complements the Lurie Cancer Center's existing Basic Science Program in Hormone Action and Signal Transduction in Cancer. The Training Program provides a training milieu that enables recent PhDs to spend two years in a structured mentored environment where they can acquire the skills and fundamental knowledge necessary before embarking on careers as independent investigators in cancer research laboratories, either in academia or in industry. Over the last ten years we have trained 26 postdoctoral fellows, several of whom have achieved successful academic faculty positions or senior scientist positions in industry. It is our expectation that our trainees will continue to be appropriately prepared to meet the challenges of biomedical research in the coming years and will contribute to seminal discoveries in signaling and cancer.
This Program trains postdoctoral fellows in the field of signal transduction and cancer and prepares them for careers as independent scientists. A group of highly qualified faculty at Northwestern University who work in different areas of signaling and cancer has been assembled to provide guidance and mentorship to postdoctoral trainees.
|Huang, Tianzhi; Alvarez, Angel A; Pangeni, Rajendra P et al. (2016) A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun 7:12885|
|Zhang, L; Zhang, W; Li, Y et al. (2016) SHP-2-upregulated ZEB1 is important for PDGFRÎ±-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Oncogene 35:5641-5652|
|Chow, Christina R; Ebine, Kazumi; Knab, Lawrence M et al. (2016) Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by GÎ±13 Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling. J Biol Chem 291:1605-18|
|Kroczynska, Barbara; Rafidi, Robert L; Majchrzak-Kita, Beata et al. (2016) Interferon Î³ (IFNÎ³) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses. J Biol Chem 291:2389-96|
|Ebine, Kazumi; Chow, Christina R; DeCant, Brian T et al. (2016) Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia. Sci Rep 6:29133|
|Eckerdt, Frank; Alvarez, Angel; Bell, Jonathan et al. (2016) A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids. Biotechniques 60:43-6|
|Hamanaka, Robert B; Weinberg, Samuel E; Reczek, Colleen R et al. (2016) The Mitochondrial Respiratory Chain Is Required for Organismal Adaptation to Hypoxia. Cell Rep 15:451-9|
|Bell, Jonathan B; Eckerdt, Frank D; Alley, Kristen et al. (2016) MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma. Mol Cancer Res 14:984-993|
|Kumar, Krishan; Chow, Christina R; Ebine, Kazumi et al. (2016) Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer. Mol Cancer Res 14:216-27|
|Kohlhapp, F J; Mitra, A K; Lengyel, E et al. (2015) MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene 34:5857-68|
Showing the most recent 10 out of 81 publications